Literature DB >> 7283806

Digoxin retinal toxicity. Clinical and electrophysiological evaluation of a cone dysfunction syndrome.

R G Weleber, W T Shults.   

Abstract

A 70-year-old man was studied both during and after resolution of clinical digoxin toxicity using color vision tests, ganzfeld electroretinography and electro-oculography. Concomitant administration of quinidine sulfate probably contributed to digoxin toxicity. Abnormalities in color vision and subnormal amplitude and prolonged implicit time for cone-mediated electroretinogram (ERG) responses suggested a cone dysfunction syndrome. The electro-oculographic light-to-dark ratio during clinical toxicity was high for our laboratory, but this is probably normal. Notable improvement was seen in color vision and the ERG after cessation of digoxin therapy. Inhibition of sodium-potassium adenosine triphosphatase by digoxin probably influences normal uptake of extracellular potassium by Müller's cells and other retinal neurons. This mechanism may contribute to subnormal, prolonged cone-mediated ERG responses in retinal toxic reactions from cardiac glycosides.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7283806     DOI: 10.1001/archopht.1981.03930020442007

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  11 in total

1.  Hypnosis-associated blue-tinted vision: a case report.

Authors:  Ran D Anbar; Aaron D Savedoff
Journal:  BMC Ophthalmol       Date:  2005-12-01       Impact factor: 2.209

2.  [Bilateral reduction in vision in the morning, cardiological intensive care in the evening].

Authors:  T Menke; B Neppert
Journal:  Ophthalmologe       Date:  2008-06       Impact factor: 1.059

3.  Acquired colour vision deficiency in patients receiving digoxin maintenance therapy.

Authors:  J G Lawrenson; C Kelly; A L Lawrenson; J Birch
Journal:  Br J Ophthalmol       Date:  2002-11       Impact factor: 4.638

4.  On the ocular distribution of cardiac glycosides in guinea pigs following acute administration.

Authors:  G Duncker; S Herzig
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

Review 5.  Clinically important ocular reactions to systemic drug therapy.

Authors:  I G Rennie
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

Review 6.  Spectrum of digoxin-induced ocular toxicity: a case report and literature review.

Authors:  Delphine Renard; Eve Rubli; Nathalie Voide; François-Xavier Borruat; Laura E Rothuizen
Journal:  BMC Res Notes       Date:  2015-08-23

7.  Digoxin-induced retinal degeneration depends on rhodopsin.

Authors:  Britta Landfried; Marijana Samardzija; Maya Barben; Christian Schori; Katrin Klee; Federica Storti; Christian Grimm
Journal:  Cell Death Dis       Date:  2017-03-16       Impact factor: 8.469

8.  Colored floaters as a manifestation of digoxin toxicity.

Authors:  Lynn Shi; Linus D Sun; Jeffrey G Odel
Journal:  Am J Ophthalmol Case Rep       Date:  2018-03-02

Review 9.  Roles of Drug Transporters in Blood-Retinal Barrier.

Authors:  Li Liu; Xiaodong Liu
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

10.  Digoxin Inhibits Induction of Experimental Autoimmune Uveitis in Mice, but Causes Severe Retinal Degeneration.

Authors:  Samuel J H Hinshaw; Osato Ogbeifun; Wambui S Wandu; Cancan Lyu; Guangpu Shi; Yichao Li; Haohua Qian; Igal Gery
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-03       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.